Melatonin
Natural health product licensed in Canada
- Other names
- Melatonin 10 mg
- Licence holder
- Assured Natural Distribution Inc.
- NPN or DIN-HM
- 80083539
- Status
- Active licence
- Licence date
- 2 March 2018
- Revision date
- 2 April 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Mélatonine | 10 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose, Lactose monohydraté, Saveur de menthe poivrée, Croscarmellose de sodium, Stéarate de magnésium, Saveur
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps (to) increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps (to) prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people/if travelling by plane easterly across two or more time zones/flying east over two or more time zones). Helps (to) speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder. Helps (to) re-set the body’s sleep-wake cycle (aspect of the circadian rhythm). (Used as a) sleep aid (to help promote sleep).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Effets indésirables connus
Stop use if allergy occurs or if you experience headache, confusion, or nausea.
- Précautions et mises en garde
Ask a health care practitioner before use if you are taking medications for seizure, blood pressure, to suppress the immune system, to affect the mental state or increase sedation, steroids or blood thinners. Ask a health care practitioner before use if you have a cardiovascular, immune, liver or kidney disease, seizure disorder, asthma or diabetes. Ask a health care practitioner if symptoms persist for more than 4 weeks (chronic insomnia). When using this product avoid taking with alcohol or products that cause drowsiness. When using this product avoid driving or using machinery for 5 hours. Keep out of the reach of children.
Source
Official Health Canada record, licence 80083539
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.